1,240
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke’s Cognitive Examination–Revised, and Montreal Cognitive Assessment

, , , , &
Pages 107-122 | Received 29 Jan 2016, Accepted 29 Mar 2017, Published online: 24 Apr 2017

References

  • Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence, 81(3), 313–322. doi:10.1016/j.drugalcdep.2005.08.003
  • Alexopoulos, P., Ebert, A., Richter-Schmidinger, T., Scholl, E., Natale, B., Aguilar, C. A., … Kornhuber, J. (2010). Validation of the German revised Addenbrooke’s cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer’s disease and frontotemporal lobar degeneration. Dementia and Geriatric Cognitive Disorders, 29(5), 448–456. doi:10.1159/000312685
  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
  • Bates, M. E., Pawlak, A. P., Tonigan, J. S., & Buckman, J. F. (2006). Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychology of Addictive Behaviors, 20(3), 251–253. doi:10.1037/0893-164X.20.3.241
  • Berg, E. A. (1948). A simple objective technique for measuring flexibility in thinking. The Journal of General Psychology, 39, 15–22. doi:10.1080/00221309.1948.9918159
  • Bernstein, I. H., Lacritz, L., Barlow, C. E., Weiner, M. F., & DeFina, L. F. (2011). Psychometric evaluation of the Montreal Cognitive Assessment (MoCA) in three diverse samples. The Clinical Neuropsychologist, 25(1), 119–126. doi:10.1080/13854046.2010.533196
  • Bocti, C., Legault, V., Leblanc, N., Berger, L., Nasreddine, Z., Beaulieu-Boire, I., … Boulanger, J.-M. (2013). Vascular cognitive impairment: Most useful subtests of the montreal cognitive assessment in minor stroke and transient ischemic attack. Dementia and Geriatric Cognitive Disorders, 36, 154–162. doi:10.1159/000351674
  • Boustani, M., Peterson, B., Hanson, L., Harris, R., & Lohr, K. N. (2003). Screening for dementia in primary care: A summary of the evidence for the us preventive services task force. Annals of Internal Medicine, 138, 927–937.
  • Bowden, S. C. (2010). Alcohol-related dementia and Wernicke-Korsakoff syndrome. In D. Ames, A. Burns, & J. O’Brien (Eds.), Dementia (4th ed.). London: Edward Arnold.
  • Burgess, P. W., & Shallice, T. (1997). The Hayling and Brixton tests. Thurston, Suffolk: Thames Valley Test Company.
  • Carvalho, V. A., Barbosa, M. T., & Caramelli, P. (2010). Brazilian version of the Addenbrooke Cognitive Examination-revised in the diagnosis of mild Alzheimer disease. Cognitive and Behavioral Neurology, 23, 8–13.
  • Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
  • Copersino, M. L., Fals-Stewart, W., Fitzmaurice, G., Schretlen, D. J., Sokoloff, J., & Weiss, R. D. (2009). Rapid cognitive screening of patients with substance use disorders. Experimental and Clinical Psychopharmacology, 17(5), 337–344. doi:10.1037/a0017260
  • Copersino, M. L., Schretlen, D. J., Fitzmaurice, G. M., Lukas, S. E., Faberman, J., Sokoloff, J., & Weiss, R. D. (2012). Effects of cognitive impairment on substance abuse treatment attendance: Predictive validation of a brief cognitive screening measure. The American Journal of Drug and Alcohol Abuse, 38(3), 246–250. doi:10.3109/00952990.2012.670866
  • Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013). Effects of cannabis on neurocognitive functioning: Recent advances, neurodevelopmental influences and sex differences. Neuropsychology Review, 23, 117–137. doi:10.1007/s11065-012-9222-1
  • Crawford, S., Whitnall, L., Robertson, J., & Evans, J. J. (2012). A systematic review of the accuracy and clinical utility of the Addenbrooke’s cognitive examination and the Addenbrooke’s cognitive examination-Revised in the diagnosis of dementia. International Journal of Geriatric Psychiatry, 27, 659–669. doi:10.1002/gps.2771
  • Cullen, B., O’Neill, B., Evans, J. J., Coen, R. F., & Lawlor, B. A. (2007). A review of screening tests for cognitive impairment. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 790–799. doi:10.1136/jnnp.2006.095414
  • deVille, M., Baker, A., Lewin, T. J., Bucci, S., & Loughland, C. (2011). Associations between substance use, neuropsychological functioning and treatment response in psychosis. Psychiatry Research, 186(2–3), 190–196. doi:10.1016/j.psychres.2010.08.025
  • Dingwall, K. M., Pinkerton, J., & Lindeman, M. A. (2013). “People like numbers”: A descriptive study of cogntiive assessment methods in clinical practice for Aboriginal Australians in the Northern Territory. BMC Psychiatry, 13, 42. doi:10.1186/1471-244X-13-42
  • Fals-Stewart, W. (1997). Ability to counselors to detect cognitive impairment among substance-abusing patients: An examination of diagnostic efficiency. Experimental and Clinical Psychopharmacology, 5(1), 39–50. doi:10.1037/1064-1297.5.1.39
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). A practical method for grading to cognitive state of patients for the clinican. Journal of Psychiatric Research, 1, 189–198. doi:10.1016/0022-3956(75)90026-6
  • Fujiwara, Y., Suzuki, H., Yasunaga, M., Sugiyama, M., Ijuin, M., Sakuma, N., … Shinkai, S. (2010). Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the montreal cognitive assessment. Geriatrics & Gerontology International, 10(3), 225–232. doi:10.1111/j.1447-0594.2010.00585.x
  • Gaber, T. A. (2008). Evaluation of the Addenbrooke’s cognitive examination’s validity in a brain injury rehabilitation setting. Brain Injury, 22(7–8), 589–593. doi:10.1080/02699050802132461
  • Gontkovsky, S. T., Hillary, F. G., & Scott, J. G. (2002). Cross-validation and test sensitivity of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Journal of Cognitive Rehabilitation, 20, 26–31.
  • Green, A., Garrick, T., Sheedy, D., Blake, H., Shores, E. A., & Harper, C. (2010). The effect of moderate to heavy alcohol consumption on neuropsychological performance as measured by the repeatable battery for the assessment of neuropsychological status. Alcoholism: Clinical and Experimental Research, 34(3), 443–450. doi:10.1111/acer.2010.34.issue-3
  • Grohman, K., & Fals-Stewart, W. (2004). The detection of cognitive impairment among substance-abusing patients: The accuracy of the neuropsychological assessment battery-screening module. Experimental and Clinical Psychopharmacology, 12, 200–207. doi:10.1037/1064-1297.12.3.200
  • Heaton, R. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtis, G. (1993). Wisconsin Card Sorting Test (WCST) manual, revised and expanded. Odessa, FL: Psychological Assessment Resources.
  • Heaton, R. K., Miller, S. W., Taylor, M. J., & Grant, I. (2004). Revised comprehensive norms for an expanded halstead reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
  • Hobart, M. P., Goldberg, R., Bartko, J. J., & Gold, J. M. (1999). Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: Convergent/discriminant validity and diagnostic group comparisons. The American Journal of Psychiatry, 156, 1951–1957.
  • Horner, M. D., Harvey, R. T., & Denier, C. A. (1999). Self-report and objective measures of cognitive deficit in patients entering substance abuse treatment. Psychiatry Research, 86(2), 155–161. doi:10.1016/S0165-1781(99)00031-1
  • Hsieh, S., Schubert, S., Hoon, C., Mioshi, E., & Hodges, J. R. (2013). Validation of the Addenbrooke’s cognitive examination III in frontotemporal dementia and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 36, 242–250. doi:10.1159/000351671
  • IBM Corporation. (2013). IBM SPSS statistics for windows, version 22.0. Armonk, NY: Author.
  • Komadina, N. C., Terpening, Z., Huang, Y., Halliday, G. M., Naismith, S. L., & Lewis, S. J. (2011). Utility and limitations of Addenbrooke’s cognitive examination-revised for detecting mild cognitive impairment in Parkinson’s disease. Dementia and Geriatric Cognitive Disorders, 31(5), 349–357. doi:10.1159/000328165
  • Kwak, Y. T., Yang, Y., & Kim, G. W. (2010). Korean Addenbrooke’s Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer’s disease and subcortical ischemic vascular dementia. Geriatrics & Gerontology International, 10(4), 295–301. doi:10.1111/j.1447-0594.2010.00624.x
  • Larner, A. J. (2013). Addenbrooke’s Cognitive Examination-Revised (ACE-R): Pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown etiology. International Journal of Geriatric Psychiatry, 28, 547–548. doi:10.1002/gps.3884
  • Larson, E. B., Kirschner, K., Bode, R., Heinemann, A., & Goodman, R. (2005). Construct and predictive validity of the repeatable battery for the assessment of neuropsychological status in the evaluation of stroke patients. Journal of Clinical and Experimental Neuropsychology, 27, 16–32. doi:10.1080/138033990513564
  • Manning, V., Betteridge, S., Wanigaratne, S., Best, D., & Strang, J. (2009). Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder. Schizophrenia Research, 114, 98–104. doi:10.1016/j.schres.2009.05.020
  • Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology, 55, 1613–1620. doi:10.1212/01.wnl.0000434309.85312.19
  • Matias-Guiu, J. A., Cortés-Martínez, A., Valles-Salgado, M., Rognoni, T., Fernández-Matarrubia, M., Moreno-Ramos, T., & Matías-Guiu, J. (2016). Addenbrooke’s cognitive examination III: Diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests. International Psychogeriatrics, 1–9. doi:10.1017/S1041610216001496
  • Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006). The Addenbrooke’s Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry, 21(11), 1078–1085. doi:10.1002/gps.1610
  • Mohs, R. C., Rosen, W. G., & Davis, K. L. (1983). The Alzheimer’s disease assessment scale: An instrument for assessing treatment efficacy. Psychopharacology Bulletin, 19, 448–450.
  • Monds, L. A., Ridley, N. J., Rivas, C., Withall, A., Draper, B., & Lintzeris, N. (2017). Cognition and adaptive functioning in older people attending drug and alcohol services. International Psychogeriatrics, 29(5), 815–823. doi:10.1212/WNL.67.12_suppl_4.S45
  • Moriyama, Y., Mimura, M., Kato, M., & Kashima, H. (2006). Primary alcoholic dementia and alcohol-related dementia. Psychogeriatrics, 6, 114–118. doi:10.1111/psy.2006.6.issue-3
  • Morris, K., Hacker, V., & Lincoln, N. B. (2012). The validity of the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in acute stroke. Disability and Rehabilitation, 34(3), 189–195. doi:10.3109/09638288.2011.591884
  • Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., … Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. doi:10.1111/j.1532-5415.2005.53221.x
  • National Health and Medical Research Council. (2009). NHMRC Australian Guidelines to reduce health risks from alcohol. Canberra: Commonwealth of Australia, National Health and Medical Research Council.
  • Nazem, S., Siderowf, A. D., Duda, J. E., Have, T. T., Colcher, A., Horn, S. S., … Weintraub, D. (2009). Montreal cognitive assessment performance in patients with Parkinson’s disease with “normal” global cognition according to mini-mental state examination score. Journal of the American Geriatrics Society, 57(2), 304–308. doi:10.1111/j.1532-5415.2008.02096.x
  • Newman, J. C. (2015). Copyright and bedside cognitive testing: Why we need alternatives to the mini-mental state examination. JAMA Internal Medicine, 175(9), 1459–1460. doi:10.1001/jamainternmed.2015.2159
  • O’Bryant, S. E., Humphreys, J. D., Smith, G. E., Ivnik, R. J., Graff-Radford, N. R., Petersen, R. C., & Lucas, J. A. (2008). Detecting dementia with the mini-mental state examination (MMSE) in highly educated individuals. Archives of Neurology, 65(7), 963–967. doi:10.1001/archneur.65.7.963
  • O’Malley, S., Adamse, M., Heaton, R. K., & Gawin, F. H. (1992). Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse, 18, 131–144. doi:10.3109/00952999208992826
  • Olson, R., Parkinson, M., & McKenzie, M. (2010). Selection bias introduced by neuropsychological assessments. The Canadian Journal of Neurological Sciences, 37(2), 264–268. doi:10.1017/S0317167100010039
  • Pendlebury, S. T., Cuthbertson, F. C., Welch, S. J. V., Mehta, Z., & Rothwell, P. M. (2010). Underestimation of cognitive impairment by mini-mental state examination versus the montreal cognitive assessment in patients with transient ischemic attack and stroke: A population-based study. Stroke; a Journal of Cerebral Circulation, 41(6), 1290–1293. doi:10.1161/strokeaha.110.579888
  • Pendlebury, S. T., Mariz, J., Bull, L., Mehta, Z., & Rothwell, P. M. (2012). MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke; A Journal of Cerebral Circulation, 43(2), 464–469. doi:10.1161/STROKEAHA.111.633586
  • Perneczky, R., Pohl, C., Sorg, C., Hartmann, J., Komossa, K., Alexopoulos, P., … Kurz, A. (2006). Complex activities of daily living in mild cognitive impairment: Conceptual and diagnostic issues. Age and Ageing, 35, 240–245. doi:10.1093/ageing/afj054
  • Popovic, I. M., Seric, V., & Demarin, V. (2007). Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. Journal of the Neurological Sciences, 257(1–2), 185–193. doi:10.1016/j.jns.2007.01.029
  • RachBeisel, J., Scott, J., & Dixon, L. (1999). Co-occuring severe mental and substance use disorders: A review of recent research. Psychiatric Services, 50(11), 1427–1434. doi:10.1176/ps.50.11.1427
  • Randolph, C. (2012). RBANS update: Repeatable battery for the assessment of neuropsychological status. Bloomington, MN: Pearson Clinical Assessment.
  • Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. Journal of Clinical Neuropsychology, 20(3), 310–319. doi:10.1076/jcen.20.3.310.823
  • Reitan, R. M. (1955). The relation of the trail making test to organic brain damage. Journal of Consulting Psychology, 19, 393–394. doi:10.1037/h0044509
  • Rinn, W., Desai, N., Rosenblatt, H., & Gastfriend, D. R. (2002). Addiction denial and cognitive dysfunction: A preliminary investigation. The Journal of Neuropsychiatry and Clinical Neurosciences, 14(1), 52–57. doi:10.1176/jnp.14.1.52
  • Rittman, T., Ghosh, B. C., McColgan, P., Breen, D. P., Evans, J., Williams-Gray, C. H., … Rowe, J. B. (2013). The Addenbrooke’s cognitive examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. Journal of Neurology, Neurosurgery, and Psychiatry, 84(5), 544–551. doi:10.1136/jnnp-2012-303618
  • Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer’s disease. American Journal of Psychiatry, 141, 1356–1364. doi:10.1176/ajp.141.11.1356
  • Rossetti, H., Lacritz, L., Cullum, M., & Weiner, M. (2012). Normative data for the montreal cognitive assessment (MOCA) in a population-based sample. Neurology, 78(10), 766. doi:10.1212/01.wnl.0000413072.54070.a3
  • Schrimsher, G. W., & Parker, J. D. (2008). Changes in cognitive function during substance use disorder treatment. Journal of Psychopathology and Behavioral Assessment, 30, 146–153. doi:10.1007/s10862-007-9054-0
  • Slater, H., & Young, J. (2013). A review of brief cognitive assessment tests. Reviews in Clinical Gerontology, 23(2), 164–176. doi:10.1017/s0959259813000038
  • Storey, J. E., Rowland, J. T., Basic, D., Conforti, D. A., & Dickson, H. G. (2004). The Rowland Universal Dementia Assessment Scale (RUDAS): A multicultural cognitive assessment scale. International Psychogeriatrics, 16, 13–31.
  • Teicher, G., Horner, M. D., Roitzsch, J. C., Herron, J., & Thevos, A. (2002). Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addictive Behaviors, 27, 751–763. doi:10.1016/S0306-4603(01)00207-6
  • van Gorp, W. G., Marcotte, T. D., Sultzer, D., Hinkin, C., Mahler, M., & Cummings, J. L. (1999). Screening for dementia: Comparison of three commonly used instruments. Journal of Clinical and Experimental Neuropsychology, 21, 29–38. doi:10.1076/jcen.21.1.29.939
  • Wechsler, D. (2008). Wechsler adult intelligence scale (4th ed.). San Antonio, TX: Pearson.
  • Wester, A. J., Herten, J. C., Egger, J. I., & Kessels, R. P. (2013). Applicability of the Rivermead Behavioural Memory Test - Third Edition (RBMT-3) in Korsakoff’s syndrome and chronic alcoholics. Neuropsychiatric Disease and Treatment, 9, 875–881.
  • Wester, A. J., Westhoff, J., Kessels, R. P. C., & Egger, J. I. M. (2013). The Montreal Cognitive Asesment (MoCA) as a measure of severity of amnesia in patients with alcohol-related cognitive impairments and Korsakof syndrome. Clinical Neuropsychiatry, 10(3–4), 134–141.
  • Wong, L. L., Chan, C. C., Leung, J. L., Yung, C. Y., Wu, K. K., Cheung, S. Y. Y., & Lam, C. L. M. (2013). A validation study of the Chinese-Cantonese Addenbrooke’s cognitive Examination Revised (C-ACER). Neuropsychiatric Disease and Treatment, 9, 731–737. doi:10.2147/ndt.s45477

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.